Literature DB >> 19931366

Aromatic hydroxylation and catechol formation: a novel metabolic pathway of the growth promotor zeranol.

Andreas Hildebrand1, Erika Pfeiffer, Manfred Metzler.   

Abstract

Alpha-zearalanol (alpha-ZAL, zeranol) is a macrocyclic resorcylic acid lactone, which is highly estrogenic and used as a growth promotor for cattle in various countries. Little is known about the phase I metabolism of alpha-ZAL. We now report that alpha-ZAL and its major metabolite zearalanone (ZAN) are extensively monohydroxylated at the aromatic ring by microsomes from human liver in vitro. This novel pathway leads to catechols, the chemical structures of which were unambiguously established by the use of deuterium-labeled alpha-ZAL and ZAN, and by the synthesis of authentic standards. The aromatic hydroxylation of alpha-ZAL is almost exclusively mediated by the human cytochrome P450 (hCYP) 1A2 isoform. The catechol metabolites of alpha-ZAL and ZAN are unstable and readily oxidized to quinones, which could be detected among the metabolites of alpha-ZAL and ZAN generated by human hepatic microsomes and hCYP1A2. Furthermore, the quinone metabolites are able to form covalent adducts with N-acetylcysteine (NAC), as several of such adducts were found in microsomal incubations fortified with NAC. Aromatic hydroxylation of alpha-ZAL was also observed with bovine, porcine and rat hepatic microsomes. Further studies are needed to demonstrate the catechol pathway of alpha-ZAL in vivo and to assess its toxicological significance. Copyright 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19931366     DOI: 10.1016/j.toxlet.2009.11.014

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  6 in total

1.  Proposal for a uniform designation of zearalenone and its metabolites.

Authors:  Manfred Metzler
Journal:  Mycotoxin Res       Date:  2010-11-25       Impact factor: 3.833

Review 2.  Mycotoxins: cytotoxicity and biotransformation in animal cells.

Authors:  Jikai Wen; Peiqiang Mu; Yiqun Deng
Journal:  Toxicol Res (Camb)       Date:  2016-01-07       Impact factor: 3.524

3.  Physiologically-based toxicokinetic modeling of zearalenone and its metabolites: application to the Jersey girl study.

Authors:  Dwaipayan Mukherjee; Steven G Royce; Jocelyn A Alexander; Brian Buckley; Sastry S Isukapalli; Elisa V Bandera; Helmut Zarbl; Panos G Georgopoulos
Journal:  PLoS One       Date:  2014-12-04       Impact factor: 3.240

4.  Plant organ cultures as masked mycotoxin biofactories: Deciphering the fate of zearalenone in micropropagated durum wheat roots and leaves.

Authors:  Laura Righetti; Enrico Rolli; Gianni Galaverna; Michele Suman; Renato Bruni; Chiara Dall'Asta
Journal:  PLoS One       Date:  2017-11-16       Impact factor: 3.240

5.  Characterization of Phase I and Glucuronide Phase II Metabolites of 17 Mycotoxins Using Liquid Chromatography-High-Resolution Mass Spectrometry.

Authors:  Irina Slobodchikova; Reajean Sivakumar; Md Samiur Rahman; Dajana Vuckovic
Journal:  Toxins (Basel)       Date:  2019-07-24       Impact factor: 4.546

6.  Efficient Degradation of Zearalenone by Dye-Decolorizing Peroxidase from Streptomyces thermocarboxydus Combining Catalytic Properties of Manganese Peroxidase and Laccase.

Authors:  Xing Qin; Yanzhe Xin; Xiaoyun Su; Xiaolu Wang; Yaru Wang; Jie Zhang; Tao Tu; Bin Yao; Huiying Luo; Huoqing Huang
Journal:  Toxins (Basel)       Date:  2021-08-28       Impact factor: 4.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.